DE69404373T2 - Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln - Google Patents

Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln

Info

Publication number
DE69404373T2
DE69404373T2 DE69404373T DE69404373T DE69404373T2 DE 69404373 T2 DE69404373 T2 DE 69404373T2 DE 69404373 T DE69404373 T DE 69404373T DE 69404373 T DE69404373 T DE 69404373T DE 69404373 T2 DE69404373 T2 DE 69404373T2
Authority
DE
Germany
Prior art keywords
dermopharmaceutical
cosmetic
depigmenting agents
resorcinol derivatives
substituted resorcinol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69404373T
Other languages
English (en)
Other versions
DE69404373D1 (de
Inventor
Alain Lagrange
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of DE69404373D1 publication Critical patent/DE69404373D1/de
Application granted granted Critical
Publication of DE69404373T2 publication Critical patent/DE69404373T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69404373T 1993-04-29 1994-04-29 Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln Expired - Fee Related DE69404373T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9305076A FR2704428B1 (fr) 1993-04-29 1993-04-29 Utilisation de dérivés de la résorcine substitués en position(s) 4, 4 et 5 ou 4 et 6 dans des compositions cosmétiques ou dermopharmaceutiques à action dépigmentante.

Publications (2)

Publication Number Publication Date
DE69404373D1 DE69404373D1 (de) 1997-09-04
DE69404373T2 true DE69404373T2 (de) 1998-01-22

Family

ID=9446573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69404373T Expired - Fee Related DE69404373T2 (de) 1993-04-29 1994-04-29 Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln

Country Status (5)

Country Link
EP (1) EP0623339B1 (de)
JP (1) JP2696482B2 (de)
DE (1) DE69404373T2 (de)
ES (1) ES2105551T3 (de)
FR (1) FR2704428B1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9803596A (pt) * 1997-09-23 2000-04-25 Pfizer Prod Inc Derivados do resorcinol.
US6828460B2 (en) 1999-03-22 2004-12-07 Pfizer Inc. Resorcinol derivatives
US6878381B2 (en) 1999-03-22 2005-04-12 Pfizer, Inc Resorcinol composition
JP4433241B2 (ja) * 2000-04-10 2010-03-17 丸善製薬株式会社 白髪改善剤
WO2002024613A2 (en) * 2000-09-21 2002-03-28 Pfizer Products, Inc. Resorcinol derivatives
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US20040109832A1 (en) * 2002-12-09 2004-06-10 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Di-substituted resorcinols as skin lightening agents
US6875425B2 (en) * 2002-12-12 2005-04-05 Unilever Home & Personal Care Usa Skin lightening agents, compositions and methods
ATE405538T1 (de) * 2003-05-20 2008-09-15 Warner Lambert Co Depigmentierungsmittel
US7300646B2 (en) * 2004-02-27 2007-11-27 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Skin lightening agents, compositions and methods
EP1604643A1 (de) * 2004-06-03 2005-12-14 Cognis France, S.A.S. Kosmetische Verwendung von 3-Phenylproprionsäurederivaten
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
FR2939136B1 (fr) 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(heterocycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2939135B1 (fr) 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2953834B1 (fr) 2009-12-10 2012-01-13 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2991983B1 (fr) * 2012-06-19 2016-03-04 Oreal Nouveaux derives de resorcinol et leurs applications cosmetiques
FR2991985B1 (fr) * 2012-06-19 2019-11-08 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de nouveaux composes derives de resorcinol
FR2991984B1 (fr) * 2012-06-19 2014-07-11 Oreal Nouveaux derives de resorcinol et leur application cosmetique
EP2705830A1 (de) * 2012-09-05 2014-03-12 Laboratoire In'Oya SAS Verwendung von Spinnengiften zur Hautweißung/Depigmentierung, und Zusammensetzung mit Spinnengiftderivaten
JPWO2014092166A1 (ja) * 2012-12-13 2017-01-12 株式会社ファルネックス チロシナーゼ活性阻害剤及び美白剤
JP6313791B2 (ja) * 2013-03-08 2018-04-18 ユニリーバー・ナームローゼ・ベンノートシヤープ 皮膚科学的使用のためのレゾルシノール化合物
JP2017057148A (ja) * 2015-09-15 2017-03-23 国立大学法人高知大学 チロシナーゼ阻害剤
CN109310599B (zh) 2016-06-15 2023-01-13 联合利华知识产权控股有限公司 用于增强烷基取代的间苯二酚的透皮递送的方法和化妆品组合物
FR3066492B1 (fr) 2017-05-16 2019-05-03 L'oreal Derives de resorcinol pour leur utilisation cosmetique
FR3067027B1 (fr) 2017-05-31 2019-06-21 L'oreal Derives de resorcinol pour leur utilisation cosmetique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0651619B2 (ja) * 1988-05-09 1994-07-06 株式会社クラレ 美白剤
FR2679133B1 (fr) * 1991-07-17 1993-10-15 Oreal Utilisation de derives d'acides (2,5-dihydroxyphenyl)carboxyliques, leurs homologues et leurs sels dans la preparation d'une composition cosmetique ou dermatologique a action depigmentante.

Also Published As

Publication number Publication date
FR2704428A1 (fr) 1994-11-04
JP2696482B2 (ja) 1998-01-14
EP0623339B1 (de) 1997-07-23
DE69404373D1 (de) 1997-09-04
JPH07316034A (ja) 1995-12-05
ES2105551T3 (es) 1997-10-16
FR2704428B1 (fr) 1995-06-09
EP0623339A1 (de) 1994-11-09

Similar Documents

Publication Publication Date Title
DE69404373T2 (de) Verwendung von 4-,4- und 5-, oder 4- und 6-substituierten Resorcin-Derivaten in kosmetischen oder dermopharmazeutischen Depigmentierungsmitteln
BR8904387A (pt) Processo eletrofotografico e processo para gerar cheques pessoais
DE59407737D1 (de) Verwendung von alkandiolen in kosmetischen produkten
DE69531870D1 (de) Verwendung von sophoroselipiden in kosmetischen und dermatologischen zusammensetzungen
DE69101922D1 (de) Verwendung von pyrimidin-3-oxydderivaten zur verhütung von haarausfall und deren anwendung in topischen zusammensetzungen.
DE68906894D1 (de) Erfassung von verbrauchswerten.
ATE331719T1 (de) Verwendung von kristallformen von 2- methylthienobenzodiazepinen
DE4393944T1 (de) Verwendung von Ecdysteroiden in der Kosmetik und Dermatologie
DE69801878T2 (de) Verwendung von Oxamatderivaten als Depigmentierungsmittel
DE69400727D1 (de) Verwendung von 4-Thiuoresorcin-Derivaten in kosmetischen oder dermopharmazeutischen Zusammensetzungen zur Hautdepigmentierung
DE69807454T2 (de) Kosmetische oder dermatologische verwendung von 7-hydroxylierten steroiden
DE69414028T2 (de) Lasersystem und Verwendung des Lasersystems
DE69712578D1 (de) Verwendung mindestens eines in 6-Stellung substituierten Pyrimidin-3-oxids zur Stimulierung von Tyrosinase
DE3888953D1 (de) Verwendung von cellulase beim nassvermahlen.
DE69716002D1 (de) Verwendung von einem Glykosid-Polydimethylsiloxan als Feuchthaltemittel in einer kosmetischen oder dermatologischen Zusammensetzung
DE69316417D1 (de) Reduzierung des Stromverbrauches in Mikroprozessoren
DE59712276D1 (de) Verwendung von blütenwachs in flüssigen haarbehandlungsmitteln
DE59508900D1 (de) Verwendung von Dibrom-thiophen-carbonsäure-Derivaten als Mikrobizide
DE59910763D1 (de) Verwendung von ectoin oder ectoin-derivaten in kosmetischen formulierungen
ATA225884A (de) Verwendung von substituierten glycinamiden als antidota in herbiziden mitteln und herbizide mittel
DE59401861D1 (de) Verwendung von ferrocen
DE59308823D1 (de) Verwendung von Thioalkandionen als Aromastoffe
DE59003265D1 (de) Verwendung von nor-verapamil und nor-gallopamil als antiarteriosklerotica.
NO942686D0 (no) Anvendelse av 3-arylindol- og 3-arylindazolderivater ved behandling av psykoser
DE69600101T2 (de) Verwendung von Sulfonsäuren als Anti-Aknemittel in kosmetischen oder dermatologischen Zusammensetzungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee